Health and Healthcare

Pfizer : PFE

All Pfizer Articles

1465 Articles

Chris Lange | Jun 10, 2016 at 8:05 AM EDT

Major Pharma Has Short Sellers on the Run

The May 31 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Paul Ausick | Jun 8, 2016 at 4:01 PM EDT

The 4 Stocks That Boosted the Dow Wednesday

June 8, 2016: Markets opened higher for a third straight day Wednesday boosted by rising crude oil prices and a…

Chris Lange | Jun 2, 2016 at 10:50 AM EDT

Merrill Lynch Picks ASCO Winners

Merrill Lynch is one of the major firms that will be in attendance at the American Society of Clinical Oncology…

Chris Lange | May 29, 2016 at 10:15 AM EDT

Key Movers to Look for Ahead of ASCO

The American Society of Clinical Oncology (ASCO) is gearing up for its annual meeting. At this meeting, cancer drug developers…

Lee Jackson | May 25, 2016 at 10:05 AM EDT

4 UBS Most Preferred Pharmaceutical Stocks That Pay Big Dividends

Despite the ongoing political candidate chirping, all of these quality big pharmaceutical stocks have been around, and they will continue…

Chris Lange | May 25, 2016 at 8:15 AM EDT

Short Sellers Take Mixed Stance on Major Pharma

The May 13 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Trey Thoelcke | May 25, 2016 at 6:10 AM EDT

The 5 Most Shorted NYSE Stocks: Short Sellers Pick a New Favorite

However, one medical supply company stood out, as short sellers piled on Baxter International in the first two weeks of…

Chris Lange | May 19, 2016 at 10:20 AM EDT

8 Stocks on the Move After ASCO Cancer Abstracts

ASCO has just released the abstracts for its exhibitors ahead of the conference. For investors and analysts, sometimes winners or…

Paul Ausick | May 16, 2016 at 7:50 AM EDT

Pfizer Pays $5.2 Billion for Anacor

Pfizer has announced that it has reached a definitive agreement to acquire Anacor Pharmaceuticals in a deal valued at more…

Chris Lange | May 12, 2016 at 7:40 AM EDT

ASCO Could Make or Break These 7 Cancer Drug Trials

The king of biotech and pharma events is about to take place. The 2016 annual meeting of the American Society…

Chris Lange | May 11, 2016 at 8:45 AM EDT

Major Pharma Short Interest Continues to Recede

The short interest data have been released for the April 29 settlement date, and for most of the selected pharmaceutical…

Trey Thoelcke | May 11, 2016 at 6:20 AM EDT

The 5 Most Shorted NYSE Stocks: Short Sellers Still in Retreat

As the markets reached all-time highs last month, the short sellers were in retreat, judging by the moves in the…

Jon C. Ogg | May 10, 2016 at 8:55 AM EDT

Top Analyst Upgrades and Downgrades: Bats, Eli Lilly, Gap, Hasbro, JD.com, Nike, Pfizer, SolarCity and More

The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Bats Global Markets, Eli Lilly, Gap, Hasbro, JD.com,…

Lee Jackson | May 9, 2016 at 10:05 AM EDT

4 Top Blue Chip Dividend Stocks to Buy and Hold Forever

These stocks should do well for years regardless of who the next president is. They all have incredible franchises, long…

Paul Ausick | May 7, 2016 at 12:30 PM EDT

Analysts Adjust Predictions on Medivation Buyout Price

One time when missing earnings estimates doesn't matter much is when there is bidding war for the company. That's the…

1 … 47 48 49 50 51 … 98

Pfizer : PFE

All Pfizer Articles

Major Pharma Has Short Sellers on the Run

The 4 Stocks That Boosted the Dow Wednesday

Merrill Lynch Picks ASCO Winners

Key Movers to Look for Ahead of ASCO

4 UBS Most Preferred Pharmaceutical Stocks That Pay Big Dividends

Short Sellers Take Mixed Stance on Major Pharma

The 5 Most Shorted NYSE Stocks: Short Sellers Pick a New Favorite

8 Stocks on the Move After ASCO Cancer Abstracts

Pfizer Pays $5.2 Billion for Anacor

ASCO Could Make or Break These 7 Cancer Drug Trials

Major Pharma Short Interest Continues to Recede

The 5 Most Shorted NYSE Stocks: Short Sellers Still in Retreat

Top Analyst Upgrades and Downgrades: Bats, Eli Lilly, Gap, Hasbro, JD.com, Nike, Pfizer, SolarCity and More

4 Top Blue Chip Dividend Stocks to Buy and Hold Forever

Analysts Adjust Predictions on Medivation Buyout Price

7 Reasons Why Wall Street May Regret Trump Nominating Kevin Warsh for Fed Chair

This Overlooked Precious Metals ETF Offers a 7% Yield

Why Gold Won’t Save You in a Real Crisis (But Stocks Will)

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

7 Reasons Why Wall Street May Regret Trump Nominating Kevin Warsh for Fed Chair

This Overlooked Precious Metals ETF Offers a 7% Yield

Pfizer : PFE

All Pfizer Articles

Major Pharma Has Short Sellers on the Run

The 4 Stocks That Boosted the Dow Wednesday

Merrill Lynch Picks ASCO Winners

Key Movers to Look for Ahead of ASCO

4 UBS Most Preferred Pharmaceutical Stocks That Pay Big Dividends

Short Sellers Take Mixed Stance on Major Pharma

The 5 Most Shorted NYSE Stocks: Short Sellers Pick a New Favorite

8 Stocks on the Move After ASCO Cancer Abstracts

Pfizer Pays $5.2 Billion for Anacor

ASCO Could Make or Break These 7 Cancer Drug Trials

Major Pharma Short Interest Continues to Recede

The 5 Most Shorted NYSE Stocks: Short Sellers Still in Retreat

Top Analyst Upgrades and Downgrades: Bats, Eli Lilly, Gap, Hasbro, JD.com, Nike, Pfizer, SolarCity and More

4 Top Blue Chip Dividend Stocks to Buy and Hold Forever

Analysts Adjust Predictions on Medivation Buyout Price

7 Reasons Why Wall Street May Regret Trump Nominating Kevin Warsh for Fed Chair

This Overlooked Precious Metals ETF Offers a 7% Yield

Why Gold Won’t Save You in a Real Crisis (But Stocks Will)

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up